Get started
Author

Nicholas Waters

Observed names: N Waters, N. WATERS, N. Waters, Nicholas R. Waters, S Waters, S. Waters, Susanna E. Waters, Susanna Holm-Waters, Susanna Waters, Waters, Nicholas
Observed institutions: Uppsala University Hospital, University of Bradford, University of Cagliari, University of Cambridge, Manchester Academic Health Science Centre, Sahlgrenska University Hospital, Danderyds sjukhus, Karolinska Institutet, University of Manchester, Integrative Research Laboratories, University of Gothenburg
ORCID: 0000-0002-8688-880X
Observed ORCID: 0000-0002-8688-880X
OpenAlex ID: A5103534304
Interactions Between Monoamines, Glutamate, and GABA in Schizophrenia: New Evidence
2001 · Arvid Carlsson, Nicholas Waters, et al. · The Annual Review of Pharmacology and Toxicology · 692
Neurotransmitter interactions in schizophrenia—therapeutic implications
1999 · Arvid Carlsson, Nicholas Waters, et al. · Biological Psychiatry · 296
The dopamine D3-receptor: A postsynaptic receptor inhibitory on rat locomotor activity
1993 · N. Waters, K. Svensson, et al. · Journal of Neural Transmission · 254
Neurotransmitter aberrations in schizophrenia: New perspectives and therapeutic implications
1997 · Arvid Carlsson, Lars O. Hansson, et al. · Life Sciences · 189
A glutamatergic deficiency model of schizophrenia
1999 · A. Carlsson, L. O. Hansson, et al. · The British Journal of Psychiatry · 153
Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors
1994 · Kjell Svensson, Arvid Carlsson, et al. · European Journal of Pharmacology · 141
Locomotor inhibition by the D3 ligand R-(+)-7-OH-DPAT is independent of changes in dopamine release
1994 · K. Svensson, A. Carlsson, et al. · Journal of Neural Transmission · 133
Concomitant Release of Ventral Tegmental Acetylcholine and Accumbal Dopamine by Ghrelin in Rats
2012 · Elisabet Jerlhag, Anna Carin Janson, et al. · PLoS ONE · 114
PDF
Neurotransmitter interactions in schizophrenia-therapeutic implications
1999 · A. Carlsson, Nicholas Waters, et al. · European Archives of Psychiatry and Clinical Neuroscience · 113
substituted (S)-Phenylpiperidines and Rigid Congeners as Preferential Dopamine Autoreceptor Antagonists: Synthesis and Structure-Activity Relationships
1994 · Clas Sonesson, Chiu-Hong Lin, et al. · Journal of Medicinal Chemistry · 113
Rodent data and general hypothesis: antipsychotic action exerted through 5-HT2A receptor antagonism is dependent on increased serotonergic tone
1998 · P. Martin, N. Waters, et al. · Journal of Neural Transmission · 86
The dopamine D3 receptor and autoreceptor preferring antagonists (+)-AJ76 and (+)-UH232; a microdialysis study
1993 · Nicholas Waters, Sören Lagerkvist, et al. · European Journal of Pharmacology · 81
The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in mice
1999 · M. L. Carlsson, P. Martin, et al. · Journal of Neural Transmission · 79
MK-801-induced hyperlocomotion: Differential effects of M100907, SDZ PSD 958 and raclopride
1997 · Peter Martin, Nicholas R. Waters, et al. · European Journal of Pharmacology · 77
Efficacy and Safety of the Dopaminergic Stabilizer Pridopidine (ACR16) in Patients With Huntington's Disease
2010 · Anders Lundin, Espen Dietrichs, et al. · Clinical Neuropharmacology · 75
The dopaminergic stabilizers pridopidine (ACR16) and (−)-OSU6162 display dopamine D2 receptor antagonism and fast receptor dissociation properties
2009 · Tino Dyhring, Elsebet Ø. Nielsen, et al. · European Journal of Pharmacology · 73
Differential effects of dopamine D2 and D3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behaviour
1994 · N. Waters, L. L�fberg, et al. · Journal of Neural Transmission · 67
Altered pattern of brain dopamine synthesis in male adolescents with attention deficit hyperactivity disorder.
2006 · Hans Forssberg, Elisabeth Fernell, et al. · Behavioral and Brain Functions · 64
PDF
In vivo pharmacology of the dopaminergic stabilizer pridopidine
2010 · Henrik Ponten, Johan Kullingsjö, et al. · European Journal of Pharmacology · 62
PDF
Synthesis and Evaluation of a Set of 4-Phenylpiperidines and 4-Phenylpiperazines as D2Receptor Ligands and the Discovery of the Dopaminergic Stabilizer 4-[3-(Methylsulfonyl)phenyl]-1-propylpiperidine (Huntexil, Pridopidine, ACR16)
2010 · Fredrik Pettersson, Henrik Pontén, et al. · Journal of Medicinal Chemistry · 62
A behavioural pattern analysis of hypoglutamatergic mice - effects of four different antipsychotic agents
2001 · M. Nilsson, S. Waters, et al. · Journal of Neural Transmission · 60
Behavioral Analysis of Dopaminergic Activation in Zebrafish and Rats Reveals Similar Phenotypes
2016 · Fredrik Ek, Marcus Malo, et al. · ACS Chemical Neuroscience · 56
PDF
Long-lasting improvement following (-)-OSU6162 in a patient with Huntington’s disease
1999 · J. Tedroff, A. Ekesbo, et al. · Neurology · 44
Effects of the substituted (S)-3-phenylpiperidine (?)-OSU6162 on PET measurements in subhuman primates: Evidence for tone-dependent normalization of striatal dopaminergic activity
1998 · J. Tedroff, R. Torstenson, et al. · Synapse · 44
The apparent antipsychotic action of the 5-HT2a receptor antagonist M100907 in a mouse model of schizophrenia is counteracted by ritanserin
1997 · P. Martin, N. Waters, et al. · Journal of Neural Transmission · 43
Works count: 101
Citation count: 5,168
H-index: 35
I10-index: 67
Year
Topic
Type